Fresenius, DE000FRE5EN2

Fresenius stock slips 0.54% to EUR 53.67 before Xetra

Published on 11/17/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Fresenius operates hospitals and develops pharmaceuticals and infusion solutions. On Xetra, the stock closed at EUR 53.96 on Monday, November 16, 2026.

Healthcare portfolio remains central

  • Fresenius operates hospitals and develops pharmaceuticals and infusion solutions.
  • The company is a member of Germany's DAX index.
Fresenius, DE000FRE5EN2, Illustration mit AI erstellt.

Fresenius stock traded at EUR 53.67 on Lang & Schwarz at 07:50 CET on Tuesday, November 17, 2026, 0.54 percent below the Xetra close of Monday, November 16, 2026.

Börse Frankfurt describes Fresenius as a healthcare group operating hospitals and developing pharmaceuticals and infusion solutions.

German market conditions can be followed through the DAX.

More news and analyses on Fresenius stock.

Disclaimer...
en | DE000FRE5EN2 | FRESENIUS | boerse | 70525127 | bgmi